Skip to main content
Signal8

Vensana Capital I GP, LLC

SEC insider (Form 3/4/5 filer). CIK 0001854073. 10% Owner at SpyGlass Pharma, Inc. (SGP). 5 reported Form 4/5 transactions since Sep 2024; latest on Feb 9, 2026. Located in EDINA, MN.

Companies Vensana Capital I GP, LLC has filed insider reports for

  • SpyGlass Pharma, Inc. (SGP): 10% Owner
Vensana Capital I GP, LLC profile photo

Vensana Capital I GP, LLC

CIK: 0001854073

Transaction Breakdown

Open Market Buys (P)1 (20.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)4 (80.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SpyGlass Pharma, Inc. logo
SGP

SpyGlass Pharma, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • SpyGlass Pharma, Inc. logo
    SGP

    SpyGlass Pharma, Inc.

    Feb 9, 2026
    Conversion
    Indirect
    1.7M shares-
  • SpyGlass Pharma, Inc. logo
    SGP

    SpyGlass Pharma, Inc.

    Feb 9, 2026
    Conversion
    Indirect
    548.1K shares-
  • SpyGlass Pharma, Inc. logo
    SGP

    SpyGlass Pharma, Inc.

    Feb 9, 2026
    Conversion
    Indirect
    548.1K shares-
  • SpyGlass Pharma, Inc. logo
    SGP

    SpyGlass Pharma, Inc.

    Feb 9, 2026
    Conversion
    Indirect
    359.3K shares-
  • SpyGlass Pharma, Inc. logo
    SGP

    SpyGlass Pharma, Inc.

    Feb 9, 2026
    Purchase
    Indirect
    165K shares at avg. $16.00$2.6M

1-5 of 5